Seres Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Seres Therapeutics, Inc. (MCRB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 162.12 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-05
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 94.19K shares, a 19.21% increase year-over-year.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 67.93K shares, a 42.95% decline year-over-year.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 41.41K shares, a 97.05% decline year-over-year.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 45.33K shares, a 94.52% decline year-over-year.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 284.82K shares, a 94.24% decline from fiscal 2024.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 4.94M shares.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 778.19K shares, a 56.64% decline from fiscal 2021.
- Seres Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 1.79M shares, a 55.39% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 94.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 162.12K shares 10-Q · filed 2026-08-05 | 203.53K shares derived: sum of 3 quarters · filed 2026-08-05 | 248.86K shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 67.93K shares 10-Q · filed 2026-05-05 | 109.34K shares derived: sum of 2 quarters · filed 2026-05-05 | 154.66K shares derived: sum of 3 quarters · filed 2026-05-05 | 233.68K shares derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | 41.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 86.73K shares derived: sum of 2 quarters · filed 2026-03-12 | 165.75K shares derived: sum of 3 quarters · filed 2026-03-12 | 284.82K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 45.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 124.34K shares derived: sum of 2 quarters · filed 2025-11-05 | 243.41K shares 10-Q · filed 2025-11-05 | 1.65M shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 79.02K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 198.09K shares 10-Q · filed 2025-08-06 | 1.60M shares derived: sum of 3 quarters · filed 2025-08-06 | 2.43M shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 119.07K shares 10-Q · filed 2025-05-07 | 1.52M shares derived: sum of 2 quarters · filed 2025-05-07 | 2.35M shares derived: sum of 3 quarters · filed 2025-05-07 | 2.63M shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 1.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 2.23M shares derived: sum of 2 quarters · filed 2025-03-13 | 2.51M shares derived: sum of 3 quarters · filed 2025-03-13 | 4.94M shares 10-K · filed 2025-03-13 |
| 2024-09-30 | 827.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 1.11M shares derived: sum of 2 quarters · filed 2024-11-13 | 3.54M shares 10-Q · filed 2024-11-13 | 5.07M shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 281.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 2.71M shares 10-Q · filed 2024-08-13 | 4.24M shares derived: sum of 3 quarters · filed 2024-08-15 | 4.54M shares derived: sum of 4 quarters · filed 2024-08-15 |
| 2024-03-31 | 2.43M shares 10-Q · filed 2024-05-08 | 3.96M shares derived: sum of 2 quarters · filed 2024-08-15 | 4.26M shares derived: sum of 3 quarters · filed 2024-08-15 | 4.60M shares derived: sum of 4 quarters · filed 2024-08-15 |
| 2023-12-31 | 1.53M shares derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-15 | 1.83M shares derived: sum of 2 quarters · filed 2024-08-15 | 2.17M shares derived: sum of 3 quarters · filed 2024-08-15 | 2.34M shares 8-K · filed 2024-08-15 |
| 2023-09-30 | 306.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 640.11K shares derived: sum of 2 quarters · filed 2023-11-02 | 816.32K shares 10-Q · filed 2023-11-02 | 877.00K shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 333.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 509.39K shares 10-Q · filed 2023-08-08 | 570.06K shares derived: sum of 3 quarters · filed 2023-08-08 | 727.12K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 176.21K shares 10-Q · filed 2023-05-09 | 236.89K shares derived: sum of 2 quarters · filed 2023-05-09 | 393.94K shares derived: sum of 3 quarters · filed 2023-05-09 | 711.00K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 60.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 217.73K shares derived: sum of 2 quarters · filed 2023-03-07 | 534.79K shares derived: sum of 3 quarters · filed 2023-03-07 | 778.19K shares 10-K · filed 2023-03-07 |
| 2022-09-30 | 157.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 474.12K shares derived: sum of 2 quarters · filed 2022-11-02 | 717.51K shares 10-Q · filed 2022-11-02 | 834.64K shares derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-30 | 317.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | 560.46K shares 10-Q · filed 2022-08-03 | 677.58K shares derived: sum of 3 quarters · filed 2022-08-03 | 1.62M shares derived: sum of 4 quarters · filed 2022-08-03 |
| 2022-03-31 | 243.40K shares 10-Q · filed 2022-05-04 | 360.52K shares derived: sum of 2 quarters · filed 2022-05-04 | 1.30M shares derived: sum of 3 quarters · filed 2022-05-04 | 1.78M shares derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-12-31 | 117.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 1.06M shares derived: sum of 2 quarters · filed 2022-03-01 | 1.53M shares derived: sum of 3 quarters · filed 2022-03-01 | 1.79M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 940.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 1.42M shares derived: sum of 2 quarters · filed 2021-11-10 | 1.68M shares 10-Q · filed 2021-11-10 | 1.72M shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | 475.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 736.50K shares 10-Q · filed 2021-08-03 | 778.30K shares derived: sum of 3 quarters · filed 2021-08-03 | 975.62K shares derived: sum of 4 quarters · filed 2021-08-03 |
| 2021-03-31 | 260.97K shares 10-Q · filed 2021-05-04 | 302.77K shares derived: sum of 2 quarters · filed 2021-05-04 | 500.10K shares derived: sum of 3 quarters · filed 2021-05-04 | 1.01M shares derived: sum of 4 quarters · filed 2021-05-04 |
| 2020-12-31 | 41.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | 239.12K shares derived: sum of 2 quarters · filed 2021-03-02 | 753.03K shares derived: sum of 3 quarters · filed 2021-03-02 | 1.15M shares 10-K · filed 2021-03-02 |
| 2020-09-30 | 197.32K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 711.23K shares derived: sum of 2 quarters · filed 2020-11-09 | 1.11M shares 10-Q · filed 2020-11-09 | 1.17M shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 513.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 915.78K shares 10-Q · filed 2020-07-28 | 973.63K shares derived: sum of 3 quarters · filed 2020-07-28 | 1.33M shares derived: sum of 4 quarters · filed 2020-07-28 |
| 2020-03-31 | 401.87K shares 10-Q · filed 2020-05-07 | 459.72K shares derived: sum of 2 quarters · filed 2020-05-07 | 819.15K shares derived: sum of 3 quarters · filed 2020-05-07 | 1.26M shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 57.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 417.28K shares derived: sum of 2 quarters · filed 2020-03-02 | 854.35K shares derived: sum of 3 quarters · filed 2020-03-02 | 1.62M shares 10-K · filed 2020-03-02 |
| 2019-09-30 | 359.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 796.50K shares derived: sum of 2 quarters · filed 2019-11-05 | 1.56M shares 10-Q · filed 2019-11-05 | 1.68M shares derived: sum of 4 quarters · filed 2019-11-05 |
| 2019-06-30 | 437.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 1.20M shares 10-Q · filed 2019-08-06 | 1.32M shares derived: sum of 3 quarters · filed 2019-08-06 | 1.39M shares derived: sum of 4 quarters · filed 2019-08-06 |
| 2019-03-31 | 763.41K shares 10-Q · filed 2019-05-02 | 884.00K shares derived: sum of 2 quarters · filed 2019-05-02 | 953.50K shares derived: sum of 3 quarters · filed 2019-05-02 | 1.10M shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 120.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 190.09K shares derived: sum of 2 quarters · filed 2019-03-06 | 336.38K shares derived: sum of 3 quarters · filed 2019-03-06 | 426.51K shares 10-K · filed 2019-03-06 |
| 2018-09-30 | 69.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 215.80K shares derived: sum of 2 quarters · filed 2018-11-08 | 305.92K shares 10-Q · filed 2018-11-08 | 349.32K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 146.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 236.42K shares 10-Q · filed 2018-08-02 | 279.83K shares derived: sum of 3 quarters · filed 2018-08-02 | 446.97K shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 90.12K shares 10-Q · filed 2018-05-09 | 133.53K shares derived: sum of 2 quarters · filed 2018-05-09 | 300.67K shares derived: sum of 3 quarters · filed 2018-05-09 | 534.02K shares derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | 43.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 210.54K shares derived: sum of 2 quarters · filed 2018-03-08 | 443.90K shares derived: sum of 3 quarters · filed 2018-03-08 | 518.05K shares 10-K · filed 2018-03-08 |
| 2017-09-30 | 167.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 400.50K shares derived: sum of 2 quarters · filed 2017-11-08 | 474.65K shares 10-Q · filed 2017-11-08 | 650.75K shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 233.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 307.51K shares 10-Q · filed 2017-08-03 | 483.61K shares derived: sum of 3 quarters · filed 2017-08-03 | 630.67K shares derived: sum of 4 quarters · filed 2017-08-03 |
| 2017-03-31 | 74.16K shares 10-Q · filed 2017-05-04 | 250.25K shares derived: sum of 2 quarters · filed 2017-05-04 | 397.31K shares derived: sum of 3 quarters · filed 2017-05-04 | |
| 2016-12-31 | 176.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 323.16K shares derived: sum of 2 quarters · filed 2017-03-16 | 378.50K shares 10-K · filed 2017-03-16 | |
| 2016-09-30 | 147.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 202.41K shares 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | 55.34K shares 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 18.75K shares derived: sum of 2 quarters · filed 2016-03-14 | 70.25K shares 10-K · filed 2016-03-14 | |
| 2015-09-30 | 18.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 70.25K shares 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | 51.50K shares 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |